INFU Key Statistics, Chart & Performance
The current stock price of INFU is 9.25 USD. In the past month the price decreased by -12.07%. In the past year, price increased by 3.93%.
INFU Latest News, Press Relases and Analysis
INFU Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.66 | 101.29B | ||
| CI | THE CIGNA GROUP | 9.8 | 74.36B | ||
| LH | LABCORP HOLDINGS INC | 16.96 | 22.24B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.29 | 21.37B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.44 | 21.21B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.89B | ||
| HIMS | HIMS & HERS HEALTH INC | 71.11 | 8.68B | ||
| DVA | DAVITA INC | 13.01 | 8.59B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.76 | 6.46B | ||
| CHE | CHEMED CORP | 20.06 | 6.43B | ||
| RDNT | RADNET INC | 217.87 | 6.37B | ||
| OPCH | OPTION CARE HEALTH INC | 20.82 | 5.03B |
Related stock screener links
About INFU
Company Profile
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Company Info
INFUSYSTEM HOLDINGS INC
3851 West Hamlin Road
Rochester Hills MICHIGAN 48309 US
CEO: Richard DiIorio
Employees: 508
Phone: 12482911210
INFUSYSTEM HOLDINGS INC / INFU FAQ
Can you describe the business of INFUSYSTEM HOLDINGS INC?
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 502 full-time employees. The company went IPO on 2006-06-15. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Can you provide the latest stock price for INFUSYSTEM HOLDINGS INC?
The current stock price of INFU is 9.25 USD. The price decreased by -3.95% in the last trading session.
Does INFUSYSTEM HOLDINGS INC pay dividends?
INFU does not pay a dividend.
How is the ChartMill rating for INFUSYSTEM HOLDINGS INC?
INFU has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting INFU stock to perform?
11 analysts have analysed INFU and the average price target is 14.48 USD. This implies a price increase of 56.58% is expected in the next year compared to the current price of 9.25.
What sector and industry does INFUSYSTEM HOLDINGS INC belong to?
INFUSYSTEM HOLDINGS INC (INFU) operates in the Health Care sector and the Health Care Providers & Services industry.
Is INFUSYSTEM HOLDINGS INC (INFU) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INFU.
INFU Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to INFU. When comparing the yearly performance of all stocks, INFU is a bad performer in the overall market: 68.04% of all stocks are doing better.
INFU Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to INFU. INFU scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
INFU Financial Highlights
Over the last trailing twelve months INFU reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 333.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.63% | ||
| ROA | 5.03% | ||
| ROE | 9.3% | ||
| Debt/Equity | 0.48 |
INFU Forecast & Estimates
11 analysts have analysed INFU and the average price target is 14.48 USD. This implies a price increase of 56.58% is expected in the next year compared to the current price of 9.25.
For the next year, analysts expect an EPS growth of 165.2% and a revenue growth 6.04% for INFU